{"disease":{"id":"neuroendocrine-carcinoma-of-thymus","name":"neuroendocrine carcinoma of thymus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01563354","title":"3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07429851","title":"CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":34,"lead_sponsor_name":"European Institute of Oncology","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}